Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
Send Cancel

Marek’s disease and avian influenza vaccine developed
Scientists inserted avian influenza into the turkey herpesvirus that is used in Marek's disease vaccines.

Gene-editing technique faster than previous methods

A vaccine that offers birds protection against Marek’s disease and avian influenza has been developed by scientists at The Pirbright Institute.

Writing in the journal Vaccines, scientists describe how they used a gene-editing technique (CRISPR/Cas9 ) to insert avian influenza into the turkey herpesvirus (HVT) that is used in Marek’s disease vaccines.

The gene codes for haemagglutinin (HA) - an influenza protein that plays a vital role in the virus’ ability to infect host cells and a key target of the host immune response to block infection.

Professor Munir Iqbal, head of the Avian Influenza group at Pirbright, explains: “HVT is already widely used in vaccines against Marek’s disease and can be administered to eggs, enabling automated delivery and providing birds with protection from the day they hatch.

“The additional HA gene we have incorporated will be expressed by HVT when it replicates in host cells, meaning that a single dose of vaccine induces immunity against both viruses."

Compared to previous methods, the new technique is faster, more efficient, and will reduce the time it takes for poultry producers to update vaccine strains. This will enable a quicker response to disease outbreaks and provide better protection.

Prof Iqbal continued: “The genetic engineering process we have developed using CRISPR/Cas9 is far quicker and more efficient than previous technologies, as well as being very consistent and accurate. These attributes are essential for providing fast and reliable vaccine production to protect poultry.

“Improving how we make vaccines is critical for preventing avian influenza outbreaks. Our work could help reduce the spread of disease between birds and reduce the risk of infection for people who work closely with poultry."

Become a member or log in to add this story to your CPD history

Kennel Club appoints new chief executive

News Story 1
 The Kennel Club has announced the appointment of Mark Beazley, who was previously Cats Protection's director of operations, as chief executive. Mark replaces Rosemary Smart, who stepped down from the role in April after 18 years.

Mark has held several senior strategic and executive roles, including executive director at Dogs Trust Ireland and chair of the Companion Animal Working Group at Eurogroup for Animals. He was also heavily involved in the establishment of the Eu Cat and Dog Alliance.

Mark will take up his new role in October. 

Click here for more...
News Shorts
International Cat Care appoints new head of veterinary division

International Cat Care (ICC) has announced the appointment of Nathalie Dowgray as head of the charity's veterinary division.

Nathalie, who is an RCVS advanced practitioner in feline medicine, will lead the International Society of Feline Medicine (ISFM) and a play key role in advancing knowledge and research in feline medicine.

Claire Bessant, iCatCare's chief executive said: "We're absolutely delighted to be welcoming Nathalie to the charity. She brings a depth and breadth of feline expertise and understanding which fits perfectly with the charity's work and development, and her enthusiasm for cats is infectious."